Domagrozumab

Domagrozumab Uses, Dosage, Side Effects, Food Interaction and all others data.

Domagrozumab is under investigation in clinical trial NCT01616277 (A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects).

Trade Name Domagrozumab
Generic Domagrozumab
Domagrozumab Other Names Domagrozumab, PF-06252616
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Domagrozumab
Domagrozumab

Innovators Monograph

You find simplified version here Domagrozumab

*** Taking medicines without doctor's advice can cause long-term problems.
Share